Billiontoone Inc (BLLN)

$100.03 -8.91 (-8.18%)
Market Cap N/A
Revenue (ttm) 152.58M
Net Income (ttm) -41.57M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -27.24%
Debt to Equity Ratio N/A
Volume 461,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a l...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: (650) 460-2551
Address:
1035 O’Brien Drive, Menlo Park, United States
PhishTourFunds
PhishTourFunds Apr. 20 at 11:46 PM
$BLLN Moving since the ER beat down
0 · Reply
PhishTourFunds
PhishTourFunds Mar. 31 at 10:33 PM
$BLLN ER
0 · Reply
erevnon
erevnon Mar. 30 at 5:08 PM
Guggenheim maintains BillionToOne $BLLN at Buy and lowers the price target from $120 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Annie_Preferred
Annie_Preferred Mar. 26 at 1:39 AM
$OFRM $BLLN Just have to learn ... IPO is short for "It's Probably Overpriced!"
0 · Reply
Bazzzigar
Bazzzigar Mar. 14 at 5:53 PM
$BLLN BSX
0 · Reply
Bazzzigar
Bazzzigar Mar. 11 at 3:42 PM
$BLLN
1 · Reply
RayzorRay
RayzorRay Mar. 10 at 5:49 PM
$BLLN should go under 60 then when lockup expires, might hit 40
0 · Reply
Bazzzigar
Bazzzigar Mar. 9 at 11:02 PM
$BLLN below $60?
1 · Reply
Khalident
Khalident Mar. 5 at 6:29 PM
$BLLN why would anyone short companies trying to find a cure for diseases?
0 · Reply
v92
v92 Mar. 5 at 5:19 PM
$BLLN if you want to be a millionaire, this is your stock!!!!! If you are starting as a billionaire. 🤣🤣🤣
0 · Reply
Latest News on BLLN
BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

Apr 2, 2026, 9:00 AM EDT - 22 days ago

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

Mar 4, 2026, 4:05 PM EST - 7 weeks ago

BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Feb 17, 2026, 8:05 AM EST - 2 months ago

BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

Feb 10, 2026, 9:00 AM EST - 2 months ago

BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select®

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

Feb 9, 2026, 12:29 PM EST - 2 months ago

BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care

BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

Jan 15, 2026, 8:58 AM EST - 3 months ago

BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare

BillionToOne Provides Guidance for 2026

Jan 12, 2026, 8:05 AM EST - 3 months ago

BillionToOne Provides Guidance for 2026

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

Jan 6, 2026, 9:00 AM EST - 3 months ago

BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 8:05 AM EST - 4 months ago

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

Dec 9, 2025, 4:07 PM EST - 4 months ago

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair

BillionToOne Reports Third Quarter 2025 Results

Dec 9, 2025, 4:05 PM EST - 4 months ago

BillionToOne Reports Third Quarter 2025 Results

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

Dec 2, 2025, 8:05 AM EST - 5 months ago

BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025

Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally

Dec 1, 2025, 12:53 PM EST - 5 months ago

Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally

BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests

Dec 1, 2025, 6:49 AM EST - 5 months ago

BillionToOne wins upbeat coverage as analysts flag growth in prenatal, cancer tests

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering

Nov 6, 2025, 5:02 PM EST - 6 months ago

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

Nov 6, 2025, 12:44 PM EST - 6 months ago

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut

Molecular diagnostics firm BillionToOne raises $273 million in US IPO

Nov 5, 2025, 10:36 PM EST - 6 months ago

Molecular diagnostics firm BillionToOne raises $273 million in US IPO

BillionToOne Announces Pricing of Upsized Initial Public Offering

Nov 5, 2025, 9:53 PM EST - 6 months ago

BillionToOne Announces Pricing of Upsized Initial Public Offering

BillionToOne Announces Launch of Initial Public Offering Roadshow

Oct 29, 2025, 6:00 AM EDT - 6 months ago

BillionToOne Announces Launch of Initial Public Offering Roadshow

BillionToOne targets over $2 billion valuation in US IPO

Oct 17, 2025, 6:09 PM EDT - 6 months ago

BillionToOne targets over $2 billion valuation in US IPO

Molecular diagnostics firm BillionToOne files for US IPO

Oct 7, 2025, 6:17 PM EDT - 7 months ago

Molecular diagnostics firm BillionToOne files for US IPO

BillionToOne IPO Registration Document (S-1)

Oct 7, 2025, 5:30 PM EDT - 7 months ago

BillionToOne IPO Registration Document (S-1)

PhishTourFunds
PhishTourFunds Apr. 20 at 11:46 PM
$BLLN Moving since the ER beat down
0 · Reply
PhishTourFunds
PhishTourFunds Mar. 31 at 10:33 PM
$BLLN ER
0 · Reply
erevnon
erevnon Mar. 30 at 5:08 PM
Guggenheim maintains BillionToOne $BLLN at Buy and lowers the price target from $120 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Annie_Preferred
Annie_Preferred Mar. 26 at 1:39 AM
$OFRM $BLLN Just have to learn ... IPO is short for "It's Probably Overpriced!"
0 · Reply
Bazzzigar
Bazzzigar Mar. 14 at 5:53 PM
$BLLN BSX
0 · Reply
Bazzzigar
Bazzzigar Mar. 11 at 3:42 PM
$BLLN
1 · Reply
RayzorRay
RayzorRay Mar. 10 at 5:49 PM
$BLLN should go under 60 then when lockup expires, might hit 40
0 · Reply
Bazzzigar
Bazzzigar Mar. 9 at 11:02 PM
$BLLN below $60?
1 · Reply
Khalident
Khalident Mar. 5 at 6:29 PM
$BLLN why would anyone short companies trying to find a cure for diseases?
0 · Reply
v92
v92 Mar. 5 at 5:19 PM
$BLLN if you want to be a millionaire, this is your stock!!!!! If you are starting as a billionaire. 🤣🤣🤣
0 · Reply
Bazzzigar
Bazzzigar Mar. 5 at 4:08 PM
$BLLN been warning
0 · Reply
Bazzzigar
Bazzzigar Mar. 5 at 3:44 PM
$BLLN JUNK
1 · Reply
erevnon
erevnon Mar. 5 at 11:26 AM
BTIG maintains BillionToOne $BLLN at Buy and lowers the price target from $160 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 4 at 11:12 PM
$BLLN Current Stock Price: $80.42 Contracts to trade: $80.0 BLLN Mar 20 2026 Call Entry: $5.00 Exit: $8.51 ROI: 70% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Dieseld28
Dieseld28 Mar. 4 at 11:08 PM
$BLLN BillionToOne Q3 EPS $0.10 Misses $0.16 Estimate, Sales $83.500M Beat $82.814M Estimate https://www.webull.com/news/13998972210430976
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 4 at 10:52 PM
$BLLN Q4 '25 Earnings Results & Recap BillionToOne expects full year 2026 revenue of $430M to $445M, representing 41% to 46% growth over 2025, and anticipates positive GAAP operating income for the full year 2026.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 4 at 10:52 PM
$BLLN Q4 '25 Earnings Results & Recap BillionToOne raised its full year 2026 total revenue guidance to $430M to $445M, representing 41% to 46% growth over 2025, and expects positive GAAP operating income.
0 · Reply
Bazzzigar
Bazzzigar Mar. 4 at 9:21 PM
$BLLN as expected
1 · Reply
Bazzzigar
Bazzzigar Feb. 28 at 12:01 AM
$BLLN BSX
0 · Reply
Annie_Preferred
Annie_Preferred Feb. 27 at 3:44 PM
$BLLN Geez ... maybe billion to one is how the stock price goes?
0 · Reply
Bazzzigar
Bazzzigar Feb. 25 at 6:21 PM
$BLLN as expected
0 · Reply
mollielatham
mollielatham Feb. 24 at 6:04 PM
$BLLN Cramer recommended this - was out at 90
1 · Reply